CD45-antibody-drug conjugate clears tissue resident myeloid cells from their niches enabling therapeutic adoptive cell transfer
K. Gustafsson, C. Rhee, V. Frodermann, E. W. Scadden, Y. Iwamoto, R. Palchaudhuri, S. L. Hyzy, A. E. Boitano, M. Nahrendorf, D. Scadden
This study shows that anti-CD45-ADC clears tissue-resident myeloid cells, enabling efficient replacement with donor cells and reducing atherosclerotic plaque burden.
bioRxiv · Sep 5, 2023 · PreprintImmunology